
AssurantAIZ
The latest on Assurant
Our stories first, then the headlines that could move it, newest first.
We haven't written about Assurant yet. Follow it, and its first story will show under My stocks.
Quality and valuation
How Assurant compares with other financials stocks. A description, not a recommendation.
BRK.B
JPM
V
MA
BAC
MS
AIZAssurant and 6 multi-line insurance peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.
An average business among financials companies, priced about in line with them.
Assurant trades at 13.0 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.
- Revenue grew slower than the sector median: +9.4% vs +10.2%
- Turns less of its sales into cash: 12.3% vs 20.3%
- Keeps less of its revenue as profit (net margin): 7.9% vs 20.7%
Financials
From Assurant's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.
| Last 12 months | AIZ | Sector median |
|---|---|---|
| Revenue growth | +9.4% | +10.2% |
| Free cash flow margin | 12.3% | 20.3% |
| Price to earnings | 12.5x | 14.6x |
Similar companies
Multi-line Insurance, by market value.
| Company | Price | Today |
|---|---|---|
BRK.BBerkshire Hathaway | $542.49 | +0.10% |
JPMJPMorgan Chase | $337.04 | −1.90% |
VVisa | $413.59 | +0.74% |
MAMastercard | $638.01 | +0.36% |
BACBank of America | $50.01 | −2.21% |
HSBCHSBC | $85.42 | −1.36% |
MSMorgan Stanley | $184.30 | −2.41% |
GSGoldman Sachs | $894.55 | −3.58% |

